HRAS and Merkel cell skin cancer: There was no significant difference in PFS or DSS detected based on the patients' initial NSE or ChrA blood levels (first assessment after diagnosis of MCC, Figure 1), suggesting that initial NSE and ChrA levels are not effective as prognostic biomarkers.